Cargando…
Potential role of two novel agonists of thyroid hormone receptor‐β on liver regeneration
OBJECTIVES: Although the hepatomitogenic activity of triiodothyronine (T3) is well established, the wide range of harmful effects exerted by this hormone precludes its use in liver regenerative therapy. Selective agonists of the beta isoform of thyroid hormone receptor (TRβ) do not exhibit T3‐induce...
Autores principales: | Perra, Andrea, Kowalik, Marta Anna, Cabras, Lavinia, Runfola, Massimiliano, Sestito, Simona, Migliore, Cristina, Giordano, Silvia, Chiellini, Grazia, Rapposelli, Simona, Columbano, Amedeo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260063/ https://www.ncbi.nlm.nih.gov/pubmed/32347601 http://dx.doi.org/10.1111/cpr.12808 |
Ejemplares similares
-
TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD
por: Caddeo, Andrea, et al.
Publicado: (2021) -
Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders
por: Saponaro, Federica, et al.
Publicado: (2020) -
New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective
por: Sestito, Simona, et al.
Publicado: (2018) -
Collecting data through high throughput in vitro early toxicity and off-target liability assays to rapidly identify limitations of novel thyromimetics
por: Runfola, Massimiliano, et al.
Publicado: (2020) -
SUN-717 SG-2 a Novel Multi-Target Directed Ligand (MTDL) for the Treatment of Neurodegenerative Diseases (NDDS)
por: Sestito, Simona, et al.
Publicado: (2020)